Genome engineering with Cre-loxP
- PMID: 23794700
- PMCID: PMC3818143
- DOI: 10.4049/jimmunol.1301241
Genome engineering with Cre-loxP
Conflict of interest statement
The author has no financial conflict of interest.
Comment on
-
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.J Immunol. 2013 Jul 1;191(1):7-16. J Immunol. 2013. PMID: 23794701 No abstract available.
Similar articles
-
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting.J Immunol. 2013 Jul 1;191(1):7-16. J Immunol. 2013. PMID: 23794701 No abstract available.
-
The LoxP/CRE system and genome modification.Methods Mol Biol. 2001;158:83-94. doi: 10.1385/1-59259-220-1:83. Methods Mol Biol. 2001. PMID: 11236673 Review. No abstract available.
-
Cre/loxP recombination system and gene targeting.Methods Mol Biol. 2002;180:175-204. doi: 10.1385/1-59259-178-7:175. Methods Mol Biol. 2002. PMID: 11873650 Review. No abstract available.
-
A Cre-loxP solution for defining the brain renin-angiotensin system. Focus on "Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain".Physiol Genomics. 2004 Jun 17;18(1):1-3. doi: 10.1152/physiolgenomics.00115.2004. Epub 2004 Jun 17. Physiol Genomics. 2004. PMID: 15205485 No abstract available.
-
Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain.Physiol Genomics. 2004 Jun 17;18(1):25-32. doi: 10.1152/physiolgenomics.00048.2004. Epub 2004 Jun 17. Physiol Genomics. 2004. PMID: 15069166
Cited by
-
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.Cancer Lett. 2016 Apr 1;373(1):109-118. doi: 10.1016/j.canlet.2016.01.030. Epub 2016 Jan 21. Cancer Lett. 2016. PMID: 26806808 Free PMC article. Review.
-
Malic enzyme 1 knockout has no deleterious phenotype and is favored in the male germline under standard laboratory conditions.PLoS One. 2024 Jun 6;19(6):e0303577. doi: 10.1371/journal.pone.0303577. eCollection 2024. PLoS One. 2024. PMID: 38843233 Free PMC article.
-
A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.Front Immunol. 2018 Feb 21;9:104. doi: 10.3389/fimmu.2018.00104. eCollection 2018. Front Immunol. 2018. PMID: 29515565 Free PMC article. Review.
References
-
- Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP -mediated gene targeting. Cell. 1993;73:1155–1164. - PubMed
-
- Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 1987;51:503–512. - PubMed
-
- Branda CS, Dymecki SM. Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell. 2004;6:7–28. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources